Antioxidants regulate normal human keratinocyte differentiation

Biochemical Pharmacology

Volumn 68, Issue 6, 2004, Pages 1125-1131

  Eckert, Richard L ^a   Crish, James F ^a   Efimova, Tatiana ^a   Balasubramanian, Sivaprakasam ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant; Chemoprevention; Curcumin; EGCG; Green tea; Skin cancer

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CURCUMIN; EPIGALLOCATECHIN GALLATE; INVOLUCRIN; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR MARKER;

ANTIOXIDANT ACTIVITY; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CELL DIFFERENTIATION; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DISEASE MARKER; DRUG MECHANISM; DRUG POTENCY; GENE EXPRESSION; HUMAN; KERATINOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SKIN CANCER; TEA;

ANTICARCINOGENIC AGENTS; CATECHIN; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CURCUMIN; DRUG INTERACTIONS; HUMANS; KERATINOCYTES; MITOGEN-ACTIVATED PROTEIN KINASE 13; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); PROTEIN PRECURSORS; TEA;

EID: 4143116952     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.04.029     Document Type: Conference Paper

References (86)

1. Taylor G., Lehrer M.S., Jensen P.J., Sun T.T., Lavker R.M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell. 102:2000;451-461
2. Gambardella L., Barrandon Y. The multifaceted adult epidermal stem cell. Curr. Opin. Cell Biol. 15:2003;771-777
3. Sun T.T., Eichner R., Nelson W.G., Tseng S.C., Weiss R.A., Jarvinen M., et al. Keratin classes: molecular markers for different types of epithelial differentiation. J. Invest. Dermatol. 81:1983;109s-115s
4. Eckert R.L., Crish J.F., Robinson N.A. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol. Rev. 77:1997;397-424
5. Einspahr J.G., Bowden G.T., Alberts D.S. Skin cancer chemoprevention: strategies to save our skin. Recent Results Cancer Res. 163:2003;151-164
6. Einspahr J.G., Alberts D.S., Warneke J.A., Bozzo P., Basye J., Grogan T.M., et al. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis. Neoplasia. 1:1999;468-475
7. Green H. The keratinocyte as differentiated cell type. Harvey Lectures. 74:1980;101-139
8. Rice R.H., Green H. Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell. 18:1979;681-694
9. Eckert R.L., Yaffe M.B., Crish J.F., Murthy S., Rorke E.A., Welter J.F. Involucrin - structure and role in envelope assembly. J. Invest. Dermatol. 100:1993;613-617
10. Kalinin A.E., Kajava A.V., Steinert P.M. Epithelial barrier function: assembly and structural features of the cornified cell envelope. Bioessays. 24:2002;789-800
11. Ng D.C., Shafaee S., Lee D., Bikle D.D. Requirement of an AP-1 site in the calcium response region of the involucrin promoter. J Biol Chem. 275:2000;24080-24088
12. Deucher A., Efimova T., Eckert R.L. Calcium-dependent involucrin expression is inversely regulated by protein kinase C PKCalpha and PKCdelta. J. Biol. Chem. 277:2002;17032-17040
13. Efimova T., Eckert R.L. Regulation of human involucrin promoter activity by novel protein kinase C isoforms. J. Biol. Chem. 275:2000;1601-1607
14. Efimova T., LaCelle P., Welter J.F., Eckert R.L. Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP1 signal transduction pathway. J. Biol. Chem. 273:1998;24387-24395
15. Crish J.F., Howard J.M., Zaim T.M., Murthy S., Eckert R.L. Tissue-specific and differentiation-appropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotype. Differentiation. 53:1993;191-200
16. Welter J.F., Crish J.F., Agarwal C., Eckert R.L. Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity. J. Biol. Chem. 270:1995;12614-12622
17. Welter J.F., Gali H., Crish J.F., Eckert R.L. Regulation of human involucrin promoter activity by POU domain proteins. J. Biol. Chem. 271:1996;14727-14733
18. Eckert R.L., Welter J.F. Epidermal keratinoctyes - genes and their regulation. Cell Death Differ. 3:1996;373-383
19. Welter J.F., Eckert R.L. Differential expression of fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation. Oncogene. 11:1995;2681-2687
20. Agarwal C., Efimova T., Welter J.F., Crish J.F., Eckert R.L. CCAAT/enhancer-binding proteins. A role in regulation of human involucrin promoter response to phorbol ester. J. Biol. Chem. 274:1999;6190-6194
21. Balasubramanian S., Agarwal C., Efimova T., Dubyak G.R., Banks E., Welter J., et al. Thapsigargin suppresses phorbol ester-dependent human involucrin promoter activity by suppressing CCAAT-enhancer-binding protein alpha (C/EBPalpha) DNA binding. Biochem. J. 350:2000;791-796
22. Dashti S.R., Efimova T., Eckert R.L. MEK7-dependent activation of p38 MAP kinase in keratinocytes. J. Biol. Chem. 276:2001;8059-8063
23. Dashti S.R., Efimova T., Eckert R.L. MEK6 regulates human involucrin gene expression via a p38alpha- and p38delta-dependent mechanism. J. Biol. Chem. 276:2001;27214-27220
24. Efimova T., Deucher A., Kuroki T., Ohba M., Eckert R.L. Novel protein kinase C isoforms regulate human keratinocyte differentiation by activating a p38 delta mitogen-activated protein kinase cascade that targets CCAAT/enhancer-binding protein alpha. J. Biol. Chem. 277:2002;31753-31760
25. Efimova T., Broome A.M., Eckert R.L. A regulatory role for p38 delta MAPK in keratinocyte differentiation. Evidence for p38 delta-ERK1/2 complex formation. J. Biol. Chem. 278:2003;34277-34285
26. Banks E.B., Crish J.F., Eckert R.L. Transcription factor Sp1 activates involucrin promoter activity in non-epithelial cell types. Biochem. J. 337(Pt 3):1999;507-512
27. Crish J.F., Zaim T., Eckert R.L. The distal regulatory region (DRR) of the human involucrin promoter is required for expression in epidermis. J. Biol. Chem. 273:1998;30460-30465
28. Balasubramanian S., Efimova T., Eckert R.L. Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes. J. Biol. Chem. 277:2002;1828-1836
29. Banks E.B., Crish J.F., Welter J.F., Eckert R.L. Characterization of human involucrin promoter distal regulatory region transcriptional activator elements-a role for Sp1 and AP1 binding sites. Biochem. J. 331(Pt 1):1998;61-68
30. Kelloff G.J., Crowell J.A., Steele V.E., Lubet R.A., Boone C.W., Malone W.A., et al. Progress in cancer chemoprevention. Ann. NY Acad. Sci. 889:1999;1-13
31. Park A.M., Dong Z. Signal transduction pathways: targets for green and black tea polyphenols. J. Biochem. Mol. Biol. 36:2003;66-77
32. Katiyar S.K., Agarwal R., Mukhtar H. Inhibition of both stage I and stage II skin tumor promotion in SENCAR mice by a polyphenolic fraction isolated from green tea: inhibition depends on the duration of polyphenol treatment. Carcinogenesis. 14:1993;2641-2643
33. Katiyar S.K., Bergamo B.M., Vyalil P.K., Elmets C.A. Green tea polyphenols: DNA photodamage and photoimmunology. J. Photochem. Photobiol. B. 65:2001;109-114
34. Vayalil P.K., Elmets C.A., Katiyar S.K. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis. 24:2003;927-936
35. Bickers D.R., Athar M. Novel approaches to chemoprevention of skin cancer. J. Dermatol. 27:2000;691-695
36. Zhao J.F., Zhang Y.J., Jin X.H., Athar M., Santella R.M., Bickers D.R., et al. Green tea protects against psoralen plus ultraviolet A-induced photochemical damage to skin. J. Invest. Dermatol. 113:1999;1070-1075
37. Chen N.Y., Ma W.Y., Yang C.S., Dong Z. Inhibition of arsenite-induced apoptosis and AP-1 activity by epigallocatechin-3-gallate and theaflavins. J. Environ. Pathol. Toxicol. Oncol. 19:2000;287-295
38. Chung J.Y., Park J.O., Phyu H., Dong Z., Yang C.S. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. FASEB J. 15:2001;2022-2024
39. Ahmad N., Gupta S., Mukhtar H. Green tea polyphenol epigallocatechin-3- gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch. Biochem. Biophys. 376:2000;338-346
40. Balasubramanian S., Kim K.H., Ahmad N., Mukhtar H. Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse. Oncogene. 18:1999;1297-1302
41. Chung F.L., Schwartz J., Herzog C.R., Yang Y.M. Tea and cancer prevention: studies in animals and humans. J. Nutr. 133:2003;3268S-3274S
42. Pugliese P.T. The skin's antioxidant systems. Dermatol. Nurs. 10:1998;401-416
43. Gupta S., Mukhtar H. Chemoprevention of skin cancer: current status and future prospects. Cancer Metastasis Rev. 21:2002;363-380
44. Hsu S., Bollag W.B., Lewis J., Huang Q., Singh B., Sharawy M., et al. Green tea polyphenols induce differentiation and proliferation in epidermal keratinocytes. J. Pharmacol. Exp. Ther. 306:2003;29-34
45. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:1997;180-186
46. Nomura M., Ma W.Y., Huang C., Yang C.S., Bowden G.T., Miyamoto K., et al. Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea. Mol. Carcinogen. 28:2000;148-155
47. Dong Z., Ma W., Huang C., Yang C.S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res. 57:1997;4414-4419
48. Barthelman M., Bair W.B. III, Stickland K.K., Chen W., Timmermann B.N., Valcic S., et al. (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis. 19:1998;2201-2204
49. Chung J.Y., Huang C., Meng X., Dong Z., Yang C.S. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res. 59:1999;4610-4617
50. Chen W., Dong Z., Valcic S., Timmermann B.N., Bowden G.T. Inhibition of ultraviolet B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol. Carcinogen. 24:1999;79-84
51. Yang G.Y., Liao J., Li C., Chung J., Yurkow E.J., Ho C.T., et al. Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction [in process citation]. Carcinogenesis. 21:2000;2035-2039
52. Balasubramanian S., Crish J.F., Eckert R.L. Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancer binding protein function. J Biol Chem. 279:2004;24007-24014
53. Katiyar S.K., Afaq F., Azizuddin K., Mukhtar H. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol. Appl. Pharmacol. 176:2001;110-117
54. Chung J.H., Han J.H., Hwang E.J., Seo J.Y., Cho K.H., Kim K.H., et al. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB J. 17:2003;1913-1915
55. Yamamoto T., Lewis J., Wataha J., Dickinson D., Singh B., Bollag W.B., et al. Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects. J. Pharmacol. Exp. Ther. 308:2004;317-323
56. Yamamoto T., Hsu S., Lewis J., Wataha J., Dickinson D., Singh B., et al. Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J. Pharmacol. Exp. Ther. 307:2003;230-236
57. Mukhtar H., Ahmad N. Mechanism of cancer chemopreventive activity of green Tea. Proc. Soc. Exp. Biol. Med. 220:1999;234-238
58. Dong Z. Effects of food factors on signal transduction pathways. Biofactors. 12:2000;17-28
59. Bonte F., Noel-Hudson M.S., Wepierre J., Meybeck A. Protective effect of curcuminoids on epidermal skin cells under free oxygen radical stress. Planta Med. 63:1997;265-266
60. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23:2003;363-398
61. Leu T.H., Maa M.C. The molecular mechanisms for the antitumorigenic effect of curcumin. Curr. Med. Chem. Anti-Cancer Agents. 2:2002;357-370
62. Huang M.T., Wang Z.Y., Georgiadis C.A., Laskin J.D., Conney A.H. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis. 13:1992;2183-2186
63. Huang M.T., Lysz T., Ferraro T., Abidi T.F., Laskin J.D., Conney A.H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:1991;813-819
64. Huang M.T., Newmark H.L., Frenkel K. Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell Biochem. Suppl. 27:1997;26-34
65. Surh Y.J. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem. Toxicol. 40:2002;1091-1097
66. Mehta K., Pantazis P., McQueen T., Aggarwal B.B. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs. 8:1997;470-481
67. Korutla L., Cheung J.Y., Mendelsohn J., Kumar R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis. 16:1995;1741-1745
68. Manson M.M., Gescher A., Hudson E.A., Plummer S.M., Squires M.S., Prigent S.A. Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol. Lett. 112/113:2000;499-505
69. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480-481:2001;243-268
70. Phan T.T., See P., Lee S.T., Chan S.Y. Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing. J. Trauma. 51:2001;927-931
71. Surh Y. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428:1999;305-327
72. Kumar A.P., Garcia G.E., Ghosh R., Rajnarayanan R.V., Alworth W.L., Slaga T.J. 4-Hydroxy-3-methoxybenzoic acid methyl ester: a curcumin derivative targets Akt/NF kappa B cell survival signaling pathway: potential for prostate cancer management. Neoplasia. 5:2003;255-266
73. Plummer S.M., Holloway K.A., Manson M.M., Munks R.J., Kaptein A., Farrow S., et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene. 18:1999;6013-6020
74. Duvoix A., Morceau F., Delhalle S., Schmitz M., Schnekenburger M., Galteau M.M., et al. Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition. Biochem. Pharmacol. 66:2003;1475-1483
75. Lu Y.P., Chang R.L., Huang M.T., Conney A.H. Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis. 14:1993;293-297
76. Huang M.T., Lysz T., Ferraro T., Abidi T.F., Laskin J.D., Conney A.H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:1991;813-819
77. Huang M.T., Smart R.C., Wong C.Q., Conney A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48:1988;5941-5946
78. Khafif A., Schantz S.P., Chou T.C., Edelstein D., Sacks P.G. Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis. 19:1998;419-424
79. Drexler H.C. Programmed cell death and the proteasome. Apoptosis. 3:1998;1-7
80. Hatakeyama S., Nakayama K.I. Ubiquitylation as a quality control system for intracellular proteins. J. Biochem. (Tokyo). 134:2003;1-8
81. Shim M., Smart R.C. Lithium stabilizes the CCAAT/enhancer-binding protein alpha (C/EBPalpha) through a glycogen synthase kinase 3 (GSK3)-independent pathway involving direct inhibition of proteasomal activity. J. Biol. Chem. 278:2003;19674-19681
82. Hungness E.S., Robb B.W., Luo G.J., Pritts T.A., Hershko D.D., Hasselgren P.O. Proteasome inhibitors activate the transcription factors C/EBP-beta and delta in human intestinal epithelial cells. Biochem. Biophys. Res. Commun. 290:2002;469-474
83. Hattori T., Ohoka N., Inoue Y., Hayashi H., Onozaki K. C/EBP family transcription factors are degraded by the proteasome but stabilized by forming dimer. Oncogene. 22:2003;1273-1280
84. Nakayama K., Furusu A., Xu Q., Konta T., Kitamura M. Unexpected transcriptional induction of monocyte chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway. J. Immunol. 167:2001;1145-1150
85. Mukhopadhyay A., Banerjee S., Stafford L.J., Xia C., Liu M., Aggarwal B.B. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene. 21:2002;8852-8861
86. Eckert R.L., Green H. Structure and evolution of the human involucrin gene. Cell. 46:1986;583-589